The US government, led by President Trump, has recorded another big win in the battle that US law enforcement agencies have been waging for years against Google. This time, a federal court issued a landmark ruling stating...more
5/7/2025
/ Adtech ,
Advertising ,
Antitrust Litigation ,
Antitrust Violations ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Google ,
Monopolization ,
Search Engines ,
Trump Administration ,
Web Browsers
In July 2022, in a class action filed against the Central Bottling Company alleging unfair pricing of Coca-Cola, the Israeli Supreme Court ruled for the first time that a monopoly may not set an unfair excessive price. With...more
The Israeli Competition Director General recently announced he had reached an agreement with the British pharmaceutical company Leadiant Biosciences. According to the agreement, Leadiant undertook to pay ILS 110,000 to the...more
2022 was an intensive year in competition law. Material issues to the competition agenda were addressed in precedential determinations and rulings by the Competition Authority and by Israeli courts. These issues include...more
1/26/2023
/ Antitrust Litigation ,
Antitrust Provisions ,
Antitrust Violations ,
Competition ,
Competition Authorities ,
Corporate Fines ,
Criminal Liability ,
Excessive Pricing ,
Mergers ,
Monopolization ,
Premerger Notifications ,
Public Agencies ,
Resale Pricing ,
Supply Chain ,
Supreme Court of Israel
On July 26, 2022, the Israeli Supreme Court handed down a precedent-setting ruling in the Central Bottle Company (Coca-Cola Israel) case (Permission for Civil Appeal Gafniel v. Central Bottle Company Ltd.). The court...more
For the first time, the Israel Competition Authority has opened enforcement proceedings against a monopolist for abuse of its dominant position by charging an unfairly high price. Subject to a hearing, the authority intends...more
11/29/2021
/ Abuse of Dominance ,
Competition Authorities ,
Drug Pricing ,
Government Investigations ,
Israel ,
Monopolization ,
Netherlands ,
Personal Liability ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Gouging